Planet Biotechnology produced the first plant-made antibody, or “plantibody”, ever tested in a clinical trial. We are focused on discovering, developing and commercializing new antibody-based therapeutic and preventative products through cultivation of genetically modified green plants to meet significant underserved medical needs. Scientists at Planet Biotechnology identify and develop promising antibodies and receptor-antibody fusion molecules for the treatment and prevention of infectious diseases including emerging diseases and bio-threat agents. We routinely adapt our antibody and receptor-antibody products for rapid production in non-food, non-feed green plants grown in greenhouses. This same approach has been used by others to produce three anti-Ebola virus antibodies that are undergoing clinical trials in Africa.